An oral pyruvate kinase (PK) activator, mitapivat becomes the only approved option for treating anemia in both ...
Android Central on MSN
Google starts rolling out Android 16 QPR3 Beta 1.1 is rolling out with an important fix
The update, labeled Android 16 QPR3 Beta 1.1, is now rolling out to supported Pixel phones as a minor follow-up to the first ...
Google released QPR3 Beta 1.1. This hotfix stops apps from crashing on startup. Learn about new features and find the ...
The approval makes AQVESME the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, a rare blood disorder. The drug is expected ...
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name in the U.S. for thalassemia ...
Zacks Investment Research on MSN
AGIO's mitapivat gets FDA nod for thalassemia indication with REMS in label
Agios Pharmaceuticals AGIO announced that the FDA has approved Aqvesme (mitapivat) for the treatment of adult patients with ...
Google pushes Android 16 QPR3 Beta 1.1 to Pixel phones to address widespread app startup crashes, though some Microsoft apps fail.
OnePlus has started rolling out the stable Android 16 update for OnePlus 11R. Here are all details you need to know about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback